WEST Wisdom Blog

Sharing Stories from the C-Suite and Breakfast Networking on 10/26

Posted by Jaime Luna on Oct 24, 2017 3:12:50 PM
Enjoy breakfast with Yvonne Greenstreet, Chief Operating Officer and Laurie Keating, Chief Legal Counsel. They will share learnings from women in the C-suite and serving on Boards.

Learn more about Yvonne and Laurie 

Yvonne Greenstreet, MBChB, MBA is Chief Operating Officer at Alnylam Pharmaceuticals. Dr. Yvonne Greenstreet possesses 25 years of global experience in the pharmaceutical industry, where she has been in senior roles in research and development, strategy, and portfolio management. She has successfully led product development and commercialization teams in a wide range of therapy areas, bringing new medicines to patients. Yvonne was previously Senior Vice President and Head of Medicines Development at Pfizer, and a member of the executive team for the specialty business, with accountability for a portfolio that included the immuno-inflammation, vaccine, specialty neuroscience, and rare disease areas. Prior to Pfizer, Yvonne held roles of increasing responsibility at GlaxoSmithKline, including Senior Vice President and Chief of Strategy for Research and Development, Senior Vice President for Medicines Development and Chief Medical Officer for Europe. Yvonne received her medical degree (MBChB) from the University of Leeds, UK, and an MBA degree from INSEAD, France. She serves as a member of the board of directors of Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, and Indivior PLC, a global specialty pharmaceutical business. Dr. Greenstreet also serves on the Scientific Advisory Committee of the Bill and Melinda Gates Foundation.

Laurie Keating, JD is SVP, General Counsel, and Secretary at Alnylam Pharmaceuticals. Laurie Bartlett Keating joined Alnylam in 2014 with more than 25 years of executive experience at high technology and biotechnology companies. Prior to joining Alnylam, Laurie served as Senior Vice President, General Counsel and Secretary of Millennium: The Takeda Oncology Company for 9 years, responsible for setting the company’s global legal, intellectual property, and corporate quality strategies and priorities. Prior to Millennium, Laurie was co-founder and the first CEO of Hydra Biosciences, Inc. Before co-founding Hydra, she served as an executive at high-growth technology companies, including Iomega Corporation, and Sybase, Inc., a software company that grew from a few hundred to 6,000 employees during Laurie’s tenure on the management team. Based on her leadership at Sybase, Laurie was named one of the 45 most influential in-house lawyers in the United States under the age of 45. Upon graduating from law school, Laurie practiced law at McCutchen, Doyle, Brown and Enersen (now Bingham McCutchen) in San Francisco. She has a Doctor of Jurisprudence degree from the University of California, Hastings College of the Law, and a BA in Economics from the University of California at Berkeley. Laurie is a member of the Board of Directors of MassBio, and a past chair of the BIO General Counsels Committee.

Date and Time:  
October 26, 2017
7:30 - 9:00 AM

Alnylam Pharmaceuticals Cambridge, 300 Third Street, Cambridge, MA 02142

 Click here to learn more about  the event and get registered 

WEST 2016.jpg

Topics: Events, Women, Career, Community, Cambridge, Women in STEM, Networking, Upcoming Events, Discussion, Rockstars, Lessons Learned, Breakfast

Subscribe to Email Updates

Recent Posts

Posts by Topic

see all